{"resourceType": "Group", "meta": {"versionId": "3", "lastUpdated": "2023-11-24T18:06:48.642Z", "profile": ["https://hl7.org/fhir/uv/ebm/StructureDefinition/cohort-definition"]}, "id": "179507", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": {"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}}, "system": "https://fevir.net", "value": "179507", "assigner": {"display": "Computable Publishing LLC"}}], "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact", "valueRelatedArtifact": {"type": "cite-as", "citation": "CohortDefinition: Proxy criteria for surgical candidates [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179507. Revised 2023-11-24. Available at: https://fevir.net/resources/Group/179507. Computable resource at: https://fevir.net/resources/Group/179507."}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-title", "valueString": "CohortDefinition: Proxy criteria for surgical candidates"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-url", "valueUri": "https://fevir.net/resources/Group/179507"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-publisher", "valueString": "Computable Publishing LLC"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-copyright", "valueMarkdown": "https://creativecommons.org/licenses/by-nc-sa/4.0/"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-useContext", "valueUsageContext": {"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "CohortDefinition", "display": "CohortDefinition"}]}}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-contact", "valueContactDetail": {"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Brian S. Alper"}}, {"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/combination-method", "valueCode": "all-of"}], "description": "Exclusion Criteria: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months. Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease. Cardiac stress test indicating that surgery or IMM would not be safe. Pulmonary embolus or thrombophlebitis in the past six months. Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years. Significant anemia (hemoglobin 1.0 g or more below normal range) or history of coagulopathy. Serum creatinine \u2265 1.5 mg/dl. HbA1c > 14.0%.", "membership": "definitional", "characteristic": [{"code": {"text": "Defined by Reference"}, "valueReference": {"reference": "Group/170442", "type": "Group", "display": "CohortDefinition: Cardiovascular event"}, "exclude": true, "extension": [{"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months."}, {"extension": [{"url": "contextCode", "valueCodeableConcept": {"coding": [{"system": "http://snomed.info/sct", "code": "450332002", "display": "Assessment of eligibility for clinical trial (procedure)"}]}}, {"url": "offset", "valueRange": {"low": {"value": -6, "unit": "months", "system": "http://unitsofmeasure.org", "code": "mo"}, "high": {"value": 0, "unit": "months", "system": "http://unitsofmeasure.org", "code": "mo"}}}, {"url": "text", "valueString": "occurrence within the range is equivalent to 'in the past six months'"}], "url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"}]}, {"code": {"coding": [{"system": "http://snomed.info/sct", "code": "64572001", "display": "Disease (disorder)"}, {"system": "http://hl7.org/fhir/fhir-types", "code": "Condition", "display": "Condition"}]}, "valueCodeableConcept": {"coding": [{"system": "http://snomed.info/sct", "code": "59282003", "display": "Pulmonary embolism (disorder)"}]}, "exclude": true, "extension": [{"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "Pulmonary embolus in the past six months."}, {"extension": [{"url": "contextCode", "valueCodeableConcept": {"coding": [{"system": "http://snomed.info/sct", "code": "450332002", "display": "Assessment of eligibility for clinical trial (procedure)"}]}}, {"url": "offset", "valueRange": {"low": {"value": -6, "unit": "months", "system": "http://unitsofmeasure.org", "code": "mo"}, "high": {"value": 0, "unit": "months", "system": "http://unitsofmeasure.org", "code": "mo"}}}, {"url": "text", "valueString": "in the past six months"}], "url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"}]}, {"code": {"coding": [{"system": "http://snomed.info/sct", "code": "64572001", "display": "Disease (disorder)"}, {"system": "http://hl7.org/fhir/fhir-types", "code": "Condition", "display": "Condition"}]}, "valueCodeableConcept": {"coding": [{"system": "http://snomed.info/sct", "code": "64156001", "display": "Thrombophlebitis (disorder)"}]}, "exclude": true, "extension": [{"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "Thrombophlebitis in the past six months."}, {"extension": [{"url": "contextCode", "valueCodeableConcept": {"coding": [{"system": "http://snomed.info/sct", "code": "450332002", "display": "Assessment of eligibility for clinical trial (procedure)"}]}}, {"url": "offset", "valueRange": {"low": {"value": -6, "unit": "months", "system": "http://unitsofmeasure.org", "code": "mo"}, "high": {"value": 0, "unit": "months", "system": "http://unitsofmeasure.org", "code": "mo"}}}, {"url": "text", "valueString": "in the past six months"}], "url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"}]}, {"code": {"text": "Defined by Reference"}, "valueReference": {"reference": "Group/170441", "type": "Group", "display": "CohortDefinition: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years"}, "exclude": true, "extension": [{"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years."}]}, {"code": {"coding": [{"system": "http://loinc.org", "code": "718-7", "display": "Hemoglobin [Mass/volume] in Blood"}]}, "valueQuantity": {"value": -1, "comparator": "<=", "unit": "g/dL", "system": "http://unitsofmeasure.org", "code": "g/dL"}, "exclude": true, "extension": [{"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "Significant anemia (hemoglobin 1.0 g or more below normal range)"}, {"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-offset", "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/characteristic-offset", "code": "LNL", "display": "Lower Normal Limit"}]}}]}, {"code": {"coding": [{"system": "http://loinc.org", "code": "2160-0", "display": "Creatinine [Mass/volume] in Serum or Plasma"}]}, "valueQuantity": {"value": 1.5, "comparator": ">=", "unit": "mg/dl", "system": "http://unitsofmeasure.org", "code": "mg/dL"}, "exclude": true, "extension": [{"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "Serum creatinine \u2265 1.5 mg/dl"}]}, {"code": {"coding": [{"system": "http://loinc.org", "code": "59261-8", "display": "Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol"}]}, "valueQuantity": {"value": 14, "comparator": ">=", "unit": "%", "system": "http://unitsofmeasure.org", "code": "%"}, "exclude": true, "extension": [{"url": "https://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "HbA1c \u2265 14.0%"}]}], "modifierExtension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-status", "valueCode": "active"}], "type": "animal"}